Form 4: ADMA Biologics CEO Adam Grossman Executes Stock Options and Sells Shares
SEC Form 4
Adam Grossman, CEO of ADMA Biologics, exercised stock options and sold shares of common stock on August 26 and 27, 2024.
Summary
- On August 26 and 27, 2024, Adam Grossman, the President and CEO of ADMA Biologics, engaged in transactions involving the company's common stock.
- Grossman exercised options to acquire a total of 578,245 shares at prices ranging from $2.915 to $10.8.
- He then sold 626,245 shares at a weighted average price of $17.6922 on August 26 and $17.2924 on August 27.
- Following these transactions, Grossman directly owns 2,059,726 shares of common stock.
- He also indirectly owns 1,143,426 shares through Areth, LLC and 580,957 shares through Hariden, LLC.
- The exercised options were granted at various dates in the past and vested over four years.
- Some options were exercised due to their near-term expiration date.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Management Comments
- The Reporting Person is exercising these options due, in part, to their near-term expiration date.
Industry Context
This filing is a routine disclosure of insider transactions and provides transparency to investors regarding the actions of company executives.
Stakeholder Impact
- The transactions may have a short-term impact on the stock price due to the volume of shares sold.
- The filing provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 01/30/2015 | Options granted on January 30, 2015, vested over four years. |
| 10/09/2015 | Options granted on October 9, 2015, vested over four years. |
| 01/28/2016 | Options granted on January 28, 2016, vested over four years. |
| 02/14/2017 | Options granted on February 14, 2017, vested over four years. |
| 02/25/2021 | Unvested RSUs granted on February 25, 2021, vest quarterly over four years. |
| 09/29/2021 | Unvested time-based RSUs granted on September 29, 2021, vest quarterly over two years following December 31, 2022. |
| 03/07/2022 | Unvested RSUs granted on March 7, 2022, vest quarterly over four years. |
| 03/06/2023 | Unvested RSUs granted on March 6, 2023, vest quarterly over four years. |
| 08/26/2024 | Adam Grossman exercised stock options and sold shares of common stock. |
| 08/27/2024 | Adam Grossman exercised stock options and sold shares of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.